Figure 2
Survival outcomes after ICI therapy according to immunohistogram groups. (A) Progression-free survival (PFS), (B) cancer-specific survival (CSS).
Figure 2 | Scientific Reports
Survival outcomes after ICI therapy according to immunohistogram groups. (A) Progression-free survival (PFS), (B) cancer-specific survival (CSS).
